Optimum Pharma IPA+CJC 1295

Optimum Pharma IPA+CJC 1295 is a dual-peptide presentation combining Ipamorelin 2 mg and CJC-1295 2 mg per vial set, supplied as a pack of five sets. Ipamorelin is a synthetic peptide studied as a selective growth hormone secretagogue, while CJC-1295 is a synthetic growth hormone-releasing hormone analogue.

The combined product format brings two defined peptide compounds together in a clearly labelled Optimum Pharma presentation. Each set is identified as 2 mg Ipamorelin plus 2 mg CJC-1295 for laboratory catalogue comparison.

Product specifications

• Active compounds: Ipamorelin and CJC-1295
• Strength: 2 mg Ipamorelin + 2 mg CJC-1295 per set
• Product form: Dual-peptide vial presentation
• Pack size: 5 sets
• Brand: Optimum Pharma

For laboratory and research catalogue reference only. Not intended for human or veterinary use. Not intended to diagnose, treat, cure, or prevent disease. Follow applicable laws, storage requirements, and professional handling standards.